The major human apurinic and apyrimidinic (AP) endonuclease 1 Ape1 (also known as Redox factor 1 ), which is homologous to Escherichia coli exonuclease III, plays a key role in both short-patch and long-patch base excision repair (20, 40) . It cleaves the AP sites in DNA and allows them to be repaired by other enzymes involved in base excision repair (16, 23, 24) . The AP sites can be formed by chemical hydrolysis, the oxygen metabolism, ionizing radiation, UV irradiation, alkylating agents, or oxidizing agents (16, 53) . In addition, AP sites can also arise spontaneously, where it has been estimated that 20,000 purine samples and 500 pyrimidines are lost in each 24-h cell cycle in human cells (52) . The presence of AP sites blocks DNA replication, leading to DNA breakage, mutagenicity, and cytotoxicity. Ape1/Ref-1 contributes to more than 95% of the total cellular AP site-specific activity (12) , which is consistent with Ape1/Ref-1 being essential for maintaining the genomic stability.
Ape1/Ref-1 is a multifunctional protein that is not only responsible for the repair of AP sites but also stimulates the DNA-binding activity of the AP-1 family of transcription factors via a redox-dependent mechanism (1, 96) . This effect is mediated via the reduction of a conserved cysteine residue located at the DNA-binding domains of c-fos and c-jun (97) . Ape1/Ref-1 is also capable of modulating or activating other classes of transcription factors, including NF-B, p53, Egr-1, c-Myb, HLF, and Pax-8, via a similar reducing action (20) (32, 35, 73) . Studies have reported elevated Ape1/Ref-1 levels or altered subcellular localization in various types of cancers, such as epithelial ovarian cancers, cervical cancers, prostate cell tumors, melanoma, gliomas, rhabdomyosarcoma, and germ cell tumors, which are associated with tumor resistance and progression (7, 21, 22, 43, 74, 99, 100) . Ape1/Ref-1 is highly expressed in selected regions of the central nervous system (68, 95) . A reduction in Ape1/ Ref-1 expression occurs in the hippocampus after hypoxicischemic injury (93) , in the cortex after compression injury (49) , and in the spinal cord after ischemia (76 (17, 66, 83) . Thus, Ape1/Ref-1 has been implicated in tumor progression, and Ape1/Ref-1 dysfunction may contribute to development of neurodegenerative disease. However, the molecular mechanisms underlying these effects are unclear.
In the present study, we sought to determine which genes are regulated by Ape1/Ref-1, particularly those that might be involved in cancer progression and neuronal survival, using annealing control primer (ACP)-based reverse transcription-PCR (RT-PCR) analysis. Here, we report that an Ape1/Ref-1 target gene, glial cell-derived neurotropic factor (GDNF) receptor ␣1 (GFR␣1), which were identified through this screening, contributes to the Ape1/Ref-1-mediated increase in cancer cell invasion, neuronal differentiation, and survival. gen). The pShuttle-hApe1/Ref-11 construct was then doubly digested with PISceI/I-CeuI, and the purified product was ligated by using Adeno-X DNA. The DNA was subsequently linearized with PacI and purified before transfection into HEK293 cells by using Lipofectamine (Invitrogen). After transduction, HEK293 cell layers were overlaid with agarose and assessed for viral plaque formation 10 days later. For virus collection, the cells were lysed by three consecutive freezethaw cycles, and virus particles were collected from the supernatant. The virus titer was ϳ10 7 PFU/ml, which was determined by using an endpoint dilution assay. Adeno-X-LacZ adenovirus (Clontech, Mountain View, CA) was used as a control. The transduction efficiency was tested by in situ X-Gal (5-bromo-4-chloro-3-indolyl-␤-D-galactopyranoside) staining, and infection with Ad-LacZ at a multiplicity of infection of 50 to 100 resulted in 90 to 100% of the cells testing positive in GM00637 human fibroblast cells.
Human GFR␣1 cDNA was amplified by RT-PCR using GFR␣1-specific primers (5Ј-AAGGAAATAACCACCATGTTCCTGGCGACCCTGTAC-3Ј and 5Ј-TGATGTTTCTGTTAAAGATAATAGGGTGGA-3Ј) from Ape1/Ref-1-transfected GM00637 cells. Green fluorescent protein (GFP) cDNA was amplified by RT-PCR using GFP-specific primers (forward [5Ј-ATG GTG AGC AAG GGC GAG GAG]-3Ј, reverse [5Ј-CTT GTA CAG CTC GTC CAT GCC G-3Ј]) from pEGFP-N3 (Clontech). The GFR␣1 and GFP cDNAs were subcloned into pCR8GW/TOPO (K2500-20; Invitrogen) after sequencing. LR recombination reactions using pLenti6/UbC/V5-DEST (V499-10; Invitrogen), viral packaging using 293FT cells, and titration of the full lentiviral vector were performed by using the Invitrogen Gateway System and ViraPower Lentiviral Expression System. The presence of GFP and GFR␣1 was confirmed by PCR, and correct insertion of the clone was further confirmed by sequencing. Lentiviral transduction, expression, and titration were performed as specified by Invitrogen using HT-1080 cells (CCL-121; ATCC). The packed virus was concentrated by ultracentrifugation (20,000 ϫ g for 2 h at 4°C) using Centricon filters (YM-50000; Millipore, Billerica, MA).
GFR␣1 promoter constructs. Genomic DNA from human fibroblast GM00637 cells was prepared by using a Puregene DNA purification system (Gentra Systems, Inc., Minneapolis, MN) for a GFR␣1 promoter region search (National Center for Biotechnology Information, AC005872). Fragments corresponding to the GFR␣1 upstream sequence were amplified by PCR using the above DNA as a template. Each amplified fragment was then cloned into KpnI/XhoI-digested pGL3-Basic (Promega) for construction of the luciferase reporter vector. The p2284 GFR␣1 promoter construct encompassed nucleotides Ϫ2291 to Ϫ7. The p964 GFR␣1 promoter construct contained nucleotides Ϫ2291 to Ϫ1,327, which includes the GAGA box and part of Exon 2. The p509 GFR␣1 promoter construct contained nucleotides Ϫ575 to Ϫ66, which includes three putative NF-B-binding sites and part of exon 1. The p221 GFR␣1 promoter construct contained nucleotides Ϫ287 to Ϫ66, which includes one putative NF-B-binding sites. The p254 GFR␣1 promoter construct contained nucleotides Ϫ320 to Ϫ66, which includes two putative NF-B-binding site. The m-p509 GFR␣1 promoter construct contained three mutated NF-B-binding sites, which were generated using the p509 GFR␣1 promoter construct as a template with a Muta-Direct site-directed mutagenesis kit (Intron Biotechnology, Suwon, South Korea). The mutated nucleotide sequences (indicated in capital letters) were as follows: mutated NF1, 5Ј-gttggaaatCGcc-3Ј; mutated NF2, 5Ј-ggTAgagtctccg-3Ј; and mutated NF3, 5Ј-cccggagttGGct-3Ј.
Promoter luciferase activity assays. The assays were performed as previously described (103) . Luciferase activity was normalized based on the ␤-galactosidase activity and adjusted using empty pGL3-Basic vector to determine the relative luciferase activity. Each experiment was repeated at least three times.
EMSA. An electrophoretic mobility shift assay (EMSA) was carried out according to the procedure as described previously (48) . NF1 (5Ј-CCTCACCCC GGTGTTGGAAATTCCCCAAAGGCGGGA-3Ј) was used as a probe. Double-stranded NF1 was biotin labeled by using a Biotin 3Ј-End DNA labeling kit (Pierce, Rockford, IL). Antibodies to p50 (sc-114) or p52 (sc-848; Santa Cruz Biotechnology) were incubated in reaction buffer for 20 min at room temperature prior to the binding reaction.
ChIP. Chromatin immunoprecipitation (ChIP) was performed by using an EZ ChIP kit (Upstate, Temecula, CA) according to the manufacturer's instructions. The cell lysates were sonicated with five 5-s pulses using an ultrasonic processor (VCX130; Sonics & Materials, Inc., Newtown, CT) equipped with a 3-mm tip and set to 70% of maximum power. Immunoprecipitation was performed using 100 l of sheared cross-linked chromatin (corresponding to 2 ϫ 10 6 cell equivalents), 5 g of anti-p50 antibody, and 60 l of protein G-agarose. To reverse the DNA-protein cross-links, 8 l of 5 M NaCl was added to 200 l of the eluted protein-DNA complexes, followed by incubation at 65°C for 4 h. The DNA was then purified using a spin column. PCR was used to detect the p50-protected DNA fragments. The region amplified was the promoter region of human VOL. 29, 2009 Ape1/Ref-1 INDUCES GDNF RESPONSIVENESS 2265 GFR␣1 (positions Ϫ456 to Ϫ311 from ATG), which contains a putative NF-B (NF1) binding site. The DNA sequence of the 5Ј primer was 5Ј-AACCCTCTT CAGACCT-3Ј, and that of the 3Ј primer was 5Ј-CTCCCCTCCCCCGTTG-3Ј. The region amplified was also the promoter region of human GFR␣1 (positions Ϫ291 to Ϫ155 from ATG), which does not contain the NF-B (NF1) binding site. The DNA sequence of the 5Ј primer was 5Ј-CTCCGGCGCTCTCCGC-3Ј, and that of the 3Ј primer was 5Ј-CTGGCAGCAGCCACC-3Ј. Anti-rabbit immunoglobulin G was purchased from Jackson Immunoresearch Laboratories (West Grove, PA). Neurite outgrowth assay. Vector/Neuro2a cells and mock, control small interfering RNA (siRNA)-, or GFR␣1 siRNA-transfected Neuro2a/Ape1 cells were seeded in 60-mm plates at a density of 10 5 cells/well and maintained at 37°C in a humidified atmosphere of 5% CO 2 for 24 h. The cells were then transfected with pCMV-DsRed-Express (Clontech) and incubated in serum-free medium for 24 h. The cells were then treated with or without 30 ng of GDNF/ml for an additional 24 h to allow neurite elongation to proceed, and the length and number of neurites was recorded for the DsRed-positive cells by fluorescence microscopy (excitation, 540 nm; Carl Zeiss) and quantified using Axiovision 4.6 image analysis software. At least 200 cells from 9 to 12 random fields were analyzed per experiment; each experiment was performed in triplicate. The data were analyzed by factorial analysis of variance, and each value is given as the mean Ϯ the standard deviation (SD) of three independent experiments.
RT-PCR. RNA extraction was carried out by using RNA-STAT-60 according to the manufacturer's instructions (Tel-Test, Inc., Friendswood, TX). RT was performed by using the M-MLV cDNA synthesis system (Promega, , 5Ј-GUCUGGUACGACUGGAGUAtt-3Ј (sense) and 5Ј-UACUCC AGUCGUACCAGACtt-3Ј (antisense); and human GFR␣1 siRNA (1,216 bp from the ATG), 5Ј-UGUGUCGGGCAAUACACACtt-3Ј (sense) and 5Ј-GUG UGUAUUGCCCGACACAtt-3Ј (antisense). The control siRNA (AM4611) was purchased from Ambion. The control siRNA served as a negative control. The siRNAs were prepared by using a transcription-based method with a Silencer siRNA construction kit (Ambion). Mouse GFR␣1 siRNA (sc-35470) and scramble siRNA (sc-37007) were purchased from Santa Cruz. The cells were transfected with the siRNA duplexes using Lipofectamine RNAiMAX (Invitrogen).
Proliferation assays. Cells were cultured in serum free medium for 12 h. The cells were then treated with or without 10 or 30 ng of GDNF/ml in serum-free medium for the indicated times. For our siRNA studies, cells were transfected with control siRNA, Ape1/Ref-1 siRNA, or GFR␣1 siRNA 24 h prior to the addition of GDNF. In some experiments, the cells were infected with LacZ or Ape1/Ref-1 adenovirus or with GFP or GFR␣1 lentivirus 24 h before transfection with the siRNA. Cellular proliferation was determined either by MTT assay according to the manufacturer's instructions (Roche Applied Science, Mannheim, Germany) or by counting the cells under a light microscope.
Neuronal cell survival assay. Vector/Neuro2a cells and mock-, control siRNA-, or GFR␣1 siRNA-transfected Neuro2a/Ape1cells were cultured in serum-free medium for 24 h. The cells were then incubated with or without 30 ng of GDNF/ml for 30 min and treated with 15 M ␤-amyloid peptide (peptide 1-42) or 20 M H 2 O 2 for an additional 24 h, and WST-1 tetrazolium salt (Roche Applied Science) was added. After 2 h, the absorbance values at 450 nm were determined by using a Multiskan Spectrum apparatus (Thermo Labsystems, Stockholm, Sweden). The reduction of WST in the treated cells is expressed as the percentage of GDNF in the untreated vector/Neuro2a cells. All experiments were performed in triplicate.
Invasion assay. Cellular invasion was assayed in triplicate using an BioCoat Matrigel invasion chamber (BD Biosciences Discovery Labware, Bedford, MA) according to the manufacturer's instructions. The basic invasion assay was done as follows: cells were transfected with control siRNA, Ape1/Ref-1 siRNA, or GFR␣1 siRNA and allowed to recover. In some experiments, cells were infected with GFP or GFR␣1 lentivirus 24 h before siRNA transfection. At 48 h posttransfection, cells were treated with trypsin, pelleted, and resuspended in serumfree media. Approximately 2 ϫ 10 5 pancreatic cancer cells were plated in a single well of a six-well invasion chamber plate in serum-free medium containing 30 ng of GDNF/ml. A total volume of 2 ml of complete medium (10% FBS) containing 30 ng of GDNF/ml was placed in the bottom chamber to serve as a chemoattractant in the lower chamber. After 24 h (MIA PaCa-2) or 36 h (BXPC3), the cells that had invaded the lower surface of the membranes were fixed with methanol and stained with hematoxylin and eosin. The number of invading cells was determined by counting the cells that invaded to the lower side of the filter using a light microscopy at ϫ40. Ten random fields were counted for each filter, and each sample was assayed in triplicate.
Statistical analysis. All values are expressed as means Ϯ the SD. Where indicated, we performed analyses of significance by the two-tailed Student t test. We considered P Ͻ 0.05 as significant and P Ͻ 0.01 as highly significant (indicated by "*" and "**," respectively, in the figures). S1 in the supplemental material). GFR␣1, which is a key receptor for GDNF family proteins (42, 86) , promotes neuronal survival (2, 29, 44, 85) and is involved in tumor cell proliferation and invasion (79, 90) .
RESULTS

Ape1
To confirm this ACP-based RT-PCR result, semiquantitative RT-PCR analyses of Ad-LacZ-and Ad-Ape1/Ref-1-infected fibroblast cells were performed. Semiquantitative RT-PCR analysis using the GFR␣1 primers showed that the expression level of the GFR␣1 genes was increased dramatically by infecting them with Ad-Ape1/Ref-1 but not when they were infected with Ad-LacZ (Fig. 1A) . In order to determine whether this increase in the GFR␣1 mRNA levels correspond to an increase in the GFR␣1 protein level, Western blots analyses were carried out with an antibody to GFR␣1. SDS-PAGE was used to separate the whole-cell extracts of the protein from the Ape1/Ref-1-transfected cells, as well as to separate the protein from the LacZ-transfected cells. Western blot analysis with the GFR␣1 antibody showed that the GFR␣1 protein levels were higher in the Ape1/Ref-1-transfected cells than in the LacZ-transfected cells (Fig. 1B) .
Ape1/Ref-1 has been found to exhibit distinct functions that facilitate the DNA-binding activities of several transcription factors through redox-dependent and redox-independent mechanisms (20) (Fig. 2E) . Taken together, the results in Fig. 2 indicate that p50 NF-B binds specifically to putative NF-B sites present in the GFR␣1 promoter region, thus enhancing GFR␣1 expression in Ape1/Ref-1-transfected cells.
Ape1/Ref-1-mediated increase in GFR␣1 expression is contributed to the enhancement of the GDNF responsiveness in GM00637 cells. GFR␣1 interacts with the GDNF family, resulting in the activation of the intracellular pathway, which contributes to cell proliferation, survival, and differentiation (2, 78) . Therefore, we investigated whether the GFR␣1 induction mediated by Ape1/Ref-1 could promote a functional interaction with GDNF. The receptor tyrosine kinase, Ret, is a major component in the signaling cascade activated by members of the GDNF family (42, 86) . However, Ret was not detected in the parental GM00637 cells or in Ad-LacZ-and Ad-Ape1/Ref-1-infected cells (data not shown). Recent in vitro studies have shown that exogenously applied GDNF interacts with cells expressing GFR␣1, leading to the activation of the Ret-dependent and Ret-independent signal pathways (71, 72, 88) . Because Src-family kinase has been reported to be the direct downstream target of the GDNF/GFR␣ signal pathway in the Ret-deficient cell lines (71, 72, 88) , we examined whether GDNF induced Src activation by investigating the phosphorylation status of Src. We found that the Ape1/Ref (Fig. 3A) . In order to determine whether GFR␣1 contributes to Ape1/Ref-1-induced c-Src phosphorylation in response to GDNF, siRNA in the form of 21-bp RNA duplexes that target GFR␣1 was used in an attempt to inhibit its expression level. Western blot analysis revealed that the cells transfected with GFR␣1 siRNA showed Ͼ90% decreased GFR␣1 expression compared to control siRNA-transfected cells (Fig. 3A) . Indeed, the Ape1/Ref-1-infected cells treated with the GFR␣1 siRNA showed the attenuation of the GDNF-induced c-Src phosphorylation. These (15) . Immunohistochemical analysis indicated that the vector/Neuro2a cells did not express GFR␣1, whereas receptor clusters were observed in the Neuro2a/Ape1 cells (data not shown).
To determine whether increased activation of downstream signaling pathways by GDNF in Neuro2a/Ape1cells affects the outcome of GFR␣1/Ret-mediated biological responses, the effect of GDNF on neuronal differentiation and survival (50) was evaluated. In Neuro2a/Ape1cells treated with GDNF, neurite length averaged 172 Ϯ 12 m (n ϭ 200) after 24 h, which was 94% longer than the average neurite length in control neurons treated with GDNF (11 Ϯ 6 m, n ϭ 200; Fig. 6A and B) . Approximately 32% of the GDNF-treated Neuro2a/Ape1cells had four or more branches compared to 3% for the GDNFtreated controls (Fig. 6C) . Moreover, compared to the control siRNA-transfected cells, GFR␣1 siRNA-transfected Neuro2a/ Ape1cells developed short neurites in response to GDNF.
These data indicate that the Ape1/Ref-1-mediated induction of GFR␣1 leads to GDNF-induced neuroblastoma differentiation.
Finally, we examined whether APE1-induced GFR␣1 expression contributes to neuronal survival using Neuro2a/APE1 and vector/Neuro2a cells cultured with or without GDNF. GDNF-treated Neuro2a/APE1 cells showed a more rapid increase in cell number than did GDNF-treated vector/Neuro2a cells. Transfection with GFR␣1 siRNA significantly reduced cell growth in Neuro2a/APE1 cells in response to GDNF compared to control-transfected cells (see Fig. S2 in the supplemental material). In addition, treatment of Neuro2a/APE1 cells with ␤-amyloid peptide (peptide 1-42) increased cell survival compared to vector/Neuro2a cells (Fig. 6D) . Moreover, (Fig. 6E) . These results suggest that, as with neuroblastoma differentiation, the APE1-mediated increase in GFR␣1 expression promotes GDNF-induced neuronal survival.
DISCUSSION
The GDNF was originally characterized as a potent neurotropic factor specific for the survival and differentiation of the midbrain dopaminergic neurons (50) . Subsequently, the biological effects of GDNF on uterine branching in kidney morphogenesis, spermatogenesis, and survival, as well as the differentiation of several other neuronal populations, have considerably extended the range of activities of this polypeptide (60, 70, 77) . Currently, four GFR␣ proteins, GFR␣1, GFR␣2, GFR␣3, and GFR␣4 have been identified. GFR␣1 mainly binds GNDF, and GFR␣2, GFR␣3, and GFR␣4 bind neurturin, artemin, and persephin, respectively, which are the GDNF family of growth factors (5, 9, 19, 46, 51) . The GDNF protein signals through a multicomponent receptor complex, which consists of a glycosylphosphatidylinositol (GPI) binding subunit, which is known as the GDNF family receptor ␣, and the transmembrane receptor tyrosine kinase (Ret) (2, 78) . In the present study, we showed that Ape1 increased GFR␣1 expression in human fibroblast GM00637 cells (Fig. 1) . It was further found that c-Src, a downstream target protein of GFR␣1, was functionally activated by GDNF in Ape1/Ref-1-expressing GM00637 cells (Fig. 3A) and that Ape1/Ref-1-induced GFR␣1 expression contributed to the GDNF-mediated increase of cell proliferation in GM00637 cells (Fig. 3C) . Thus, these results suggest that Ape1 might influence multiple cellular processes by triggering the GDNF/GFR␣ signal pathway.
Ape1/Ref-1 is important in mediating DNA binding of the AP-1 protein complex (1, 36, 92, 96) . This occurs via a posttranslational mechanism in which conserved cysteine residues in the DNA-binding domains of Fos and Jun proteins are reduced, allowing DNA binding to occur. In addition, Ape1/ Ref-1 phosphorylation was observed in vivo, but the acceptor residues have not been identified (25, 37) . Upregulation of Ape1/Ref-1 significantly potentiates the hypoxia-induced expression of a reporter construct containing the HIF-1-binding site (38) , and Ape1/Ref-1 is thought to be critical in the linking of two coactivator proteins, CBP/p300 and SRC-1, to HIF-1␣ (10, 18) . Furthermore, Ape1/Ref-1 is found to be a component of protein complexes that binds to negative calcium response element (nCaRE) (65), Ku70(Ku86) (14) , and heterogeneous nuclear ribonucleoprotein L (47) in the promoter of the parathyroid hormone (PTH) gene, the renin gene, and the Ape1/ Ref-1 gene itself, where it may downregulate the expression of these genes (26, 41) . Recent work suggests that Ape1/Ref-1 is acetylated by CBP/p300 both in vivo and in vitro, and acetylation stimulates binding to nCaRE in the PTH promoter, leading to downregulation of the PTH gene (6) . In addition, the presence of Ape1/Ref-1 in the hypoxia-inducible transcriptional complex is required for the apparent high-affinity association between HIF-1 and its DNA recognition sequence (104) (33, 34, 55, 57) . In the present study, we found that the important of NF-B on Ape1/Ref-1-induced GFR␣1 expression using a reporter gene assay (Fig. 2B and C) . EMSA (Fig. 2D) and ChIP (Fig. 2E) GDNF-mediated activation of the GFR␣/Ret system induces the subsequent signal transduction pathway and transactivation of its target genes, which leads to cell survival and proliferation (2, 78) . Although the biological effects in nonneuronal cells are still unclear, several studies have indicated that GDNF/GFR␣/Ret system might be involved in tumor cell proliferation and invasion. For example, older mice overexpressing GDNF develop testicular carcinoma after 1 year of age as a result of an invasion of undifferentiating spermatogonia to the interstitium, suggesting that the GDNF/Ret/GFR␣ signal pathway might be implicated in human germ cell carcinogenesis (56) . In addition, the pancreatic cancer cell line contained both GFR␣1 and Ret, and GDNF increased the invasive capacity of human pancreatic cancer cell lines (90) . Despite the finding of no GFR␣1 expression in the normal bile duct, it was expressed clearly in a bile duct carcinoma, indicating that carcinogenesis leads to the aberrant expression of GFR␣1 (39 (21, 89, 94) .
In the present study, we found that both Ape1/Ref-1 and GFR␣1 proteins were highly expressed in PNAC-1, BXPC3 MIA PaCa-2, and Capan-2 cells, and the downregulation of GFR␣1 expression by Ape1/Ref-1 siRNA was observed in all of these pancreatic cancer cells (Fig. 4) . Recently, Zou et al. (105) indicated that redox domain function of Ape1 is involved in the pancreatic cancer progression. Using E330, a smallmolecule inhibitor of Ape1 redox domain function, these researchers show that selective blockade of the Ape1 redox function can inhibit pancreatic cancer growth and the migratory ability of pancreatic cancer cells in vitro. We found that the redox domain of Ape1 was essential for Ape1-mediated increase in GFR␣1 transcription (Fig. 2) . Thus, these results, combined with those of previous studies, indicate that the GFR␣1 expression or function induced by Ape1 might be involved in pancreatic cancer cell progression.
Pancreatic adenocarcinoma is a very aggressive and destructive type of cancer that is characterized by an extremely poor prognosis, pronounced invasiveness, and rapid progression (102) . A common finding in pancreatic adenocarcinoma is invasion of the intrapancreatic perineural space and the extrapancreatic retroperitoneal nerve plexus, and perineural invasion is an important prognosis factor in pancreatic cancer (8, 62) . Several lines of evidence have recently suggested that GDNF signaling may be associated with regulation of the invasive potential in human pancreatic cancer cells (27, 28, 64, 82) . The expression of MMP-2 and MMP-9 correlates with the degree of pancreatic cancer cell and lymphoid invasion (61, 101) , and GDNF stimulates both the expression and the enzymatic activity of MMP-9 in pancreatic cancer cells (64) . However, it is currently unclear which molecular mechanisms are involved in GDNF-mediated pancreatic tumor cell invasion. In the present study, we found that downregulation of Ape1 by siRNA caused a marked reduction in the GFR␣1 expression in pancreatic caner cells, as well as the diminished ability of GDNF to stimulate pancreatic cancer BXPC3 and MIA PaCa-3 invasion (Fig. 5A) . Moreover, the expression of GFR␣1 by viral vector in Ape1-depleted cells led to rescue of the GDNF-induced invasion (Fig. 5B) . Furthermore, siRNA knockdown of Ape1 or GFR␣1 in MIA PaCa-2 cells resulted in a decrease in GDNF-induced pro-MMP-9 expression (Fig. 5C) . Therefore, we postulated here that the Ape1-induced GFR␣1 expression might be an underlying mechanism of the invasive behavior of pancreatic cancer cells.
Recently (67) . In addition, young rats exhibited transient increase in Ape1/Ref-1 protein expression in the brain, including hippocampus, in response to oxidative stress, whereas aged rats showed no response (17) , suggesting that adaptation to oxidative stress is compromised in older rats. Moreover, overexpressing Ape1/Ref-1 in hippocampal and sensory cells results in a significant increase in cell viability after exposure to hydrogen peroxide (89) . Preventing the loss of Ape1/Ref-1 by inhibiting protein synthesis rescued neurons from experimentally induced cell death (13) . We have shown here that Ape1/Ref-1 expression led to enhancement of neuronal differentiation and survival (Fig. 6) , and the expression of GFR␣1 induced by Ape1/Ref-1 is required for these effects. The GDNF/GFR␣ signaling pathway promotes the survival of various neurons, including peripheral autonomic and sensory neurons, as well as central motor and dopamine neurons (3). Moreover, in various animal models of Parkinson's disease, GDNF can prevent the neurotoxin-induced death of dopamine neurons and can promote functional recovery (29, 85) . The ability of GDNF to rescue dopaminergic neurons supported idea that GDNF might ameliorate the degeneration of dopaminergic neurons in patients with Parkinson's disease. Therefore, GDNF has been considered as a therapeutic candidate for the treatment of Parkinson's disease (44) . GDNF is also a good candidate molecule for studies and possible treatment of motor neuron diseases, such as amyotrophic lateral sclerosis or acute neuronal trauma (75) . Indeed, GFR␣ is upregulated in axotomized motor neurons and in regions distal to axotomized sciatic nerves (87) . This further supports the search for a role for a GDNF/GFR␣ signaling pathway in studies of motor neuronal disease. Therefore, it is possible that Ape1/Ref-1-induced GFR␣ expression is involved in neuronal function and survival, which might suggest a protective role against the development of neurodegenerative diseases.
In summary, we show that Ape1/Ref-1 is a novel key regulator of GFR␣1. Our results indicate that an Ape1/Ref-1-mediated increase in GFR␣1 contributes to human fibroblast cell proliferation, as well as to pancreatic tumor proliferation and invasion. The connection between Ape1/Ref-1 and GFR␣1 may not be restricted to pancreatic cancer progression; GFR␣1 is also regulated by Ape1/Ref-1 in various other cancers. The relationship with GFR␣1 suggests that Ape1/Ref-1 is also directly linked to the regulation of neuronal differentiation and survival, which may be important for promoting stress resistance and regulating the cell life span under normal conditions. The connection between Ape1/Ref-1 and the GDNF/GFR␣1 pathway may be a double-edged sword, since it may affect both neuronal survival and cancer progression, depending on the site of Ape1/Ref-1 expression and on the target cell. Thus, the Ape1/Ref-1 may be a potential therapeutic target for pancreatic cancer and neurodegenerative disorders.
